Trastuzumab MMAE is an antibody-drug conjugate (ADC). It is composed of monomethyl auristatin E (MMAE) and trastuzumab conjugated via a Vc (Valine‐citrulline) linker. Trastuzumab MMAE has high affinity, specificity and anti-tumor activity in vitro.
CAS No.
| Featured Inhibitors | Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933 |
|---|
| Name | Citation | HER2 | Others |
|---|---|---|---|
| Canertinib (CI-1033) | 48 | EGFR | |
| CP-724714 | 109 | ||
| Sapitinib (AZD8931) | 50 | ErbB3,EGFR | |
| CUDC-101 | 23 | EGFR,HDAC,HDAC1 | |
| Mubritinib (TAK 165) | 40 | ||
| AEE788 (NVP-AEE788) | 13 | EGFR,c-Abl,FLT1 | |
| AC480 (BMS-599626) | 10 | HER1,HER4 | |
| TAK-285 | 4 | EGFR/HER1,HER4,MEK1 | |
| Tyrphostin AG 879 | 3 | Trk | |
| Tuxobertinib (BDTX-189) | 2 | EGFR,RIPK2,BLK | |
| Epertinib hydrochloride | 0 | EGFR,HER4 | |
| TAS0728 | 1 | ||
| Tyrphostin AG-528 | 0 | EGFR | |
| SU5204 | 1 | VEGFR-2 | |
| Pyrotinib dimaleate | 4 | EGFR | |
| Poziotinib (NOV120101, HM781-36B) | 35 | HER1,HER4 | |
| HER2-Inhibitor-1 | 1 | ||
| Zongertinib (BI 1810631) | 1 | EGFR-Ex20ins | |
| Nordihydroguaiaretic acid (NDGA) | 1 | p300,IGF-1R,lipoxygenase | |
| EGCG ((-)-Epigallocatechin Gallate) | 42 | FASN,EGFR,DNMT |
| Description |
Trastuzumab MMAE is an antibody-drug conjugate (ADC). It is composed of monomethyl auristatin E (MMAE) and trastuzumab conjugated via a Vc (Valine‐citrulline) linker. Trastuzumab MMAE has high affinity, specificity and anti-tumor activity in vitro.
|
References |
|---|
| ADC antiody | Trastuzumab |
|---|---|
| ADC linker | Vc linker |
| ADC cytotoxin | MMAE |
| Formulation | 1xPBS |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.